Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, March 25, 2026.
Coherus Oncology, Inc. (NASDAQ:CHRS)
Weak Uptrend (+65) - CHRS is showing signs of weakening momentum to the upside. Monitor CHRS as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid CHRS?
MarketClub looks at technical strength and momentum to determine if the timing is right for CHRS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CHRS
The long-term trend has been UP since Aug 22nd, 2025 at 1.15
The intermediate-term trend has been DOWN since Mar 19th, 2026 at 1.57
The short-term trend has been UP since Mar 24th, 2026 at 1.65
Smart Scan Analysis for CHRS
Based on our trend formula, CHRS is rated as a +65 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 1.7300 | 1.8500 | 1.6947 | 1.7550 | +0.0450 |
| Prev. Close | Volume | Bid | Ask | Time |
| 1.7100 | 1464757 | 2026-03-25 15:18:59 |
| Year High | 20.662 | Year High Date | 2018-08-28 |
| Year Low | 8.55 | Year Low Date | 2018-03-08 |
| 52wk High | 2.6158 | 52wk High Date | 2026-01-27 |
| 52wk Low | 0.71 | 52wk Low Date | 2025-06-23 |
| Average Volume | 1,480,354 | Shares Outstanding | 149,890 |
| Assets | 258,343,000M | Liabilities | 197,329,000M |
| P/E Ratio | 1.1958 | Volatility | 89.13 |